Analysts Reveal Their Newest Share Price Targets Wednesday

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on May 9th.

Jive Software (NASDAQ:JIVE):

UBS reiterated its rating of Neutral for this company and changed its price target from $28 to $22.

Henry Schein (NASDAQ:HSIC):

UBS reiterated its rating of Neutral for this company and changed its price target from $73 to $79.

Biogen Idec (NASDAQ:BIIB):

UBS reiterated its rating of Buy for this company and changed its price target from $135 to $148.

Body Central (NASDAQ:BODY):

Avondale reiterated its rating of Mkt Perform for this company and changed its price target from $24 to $17.

Westport Innovations (NASDAQ:WPRT):

Northland Securities reiterated its rating of Outperform for this company and changed its price target from $52 to $47.

Pike Electric (NYSE:PIKE):

Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $13 to $11.5.

Plains All Amer (NYSE:PAA):

Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $83.5 to $85.

Avalon Rare Metals (AMEX:AVL):

Dahlman Rose reiterated its rating of Buy for this company and changed its price target from $8 to $3.65.

Tempur-Pedic (NYSE:TPX):

Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $90 to $75.

Blue Nile (NASDAQ:NILE):

The Benchmark Company reiterated its rating of Hold for this company and changed its price target from $22 to $32.

Dun & Bradstreet (NYSE:DNB):

The Benchmark Company reiterated its rating of Hold for this company and changed its price target from $82 to $68.

M/A-COM Tech (MTSI):

Needham reiterated its rating of Buy for this company and changed its price target from $25 to $22.

Commvault Systems (NASDAQ:CVLT):

Wunderlich reiterated its rating of Hold for this company and changed its price target from $37 to $56. Mizuho reiterated its rating of Neutral for this company and changed its price target from $51 to $48. Needham reiterated its rating of Buy for this company and changed its price target from $55 to $61.

Par Pharmaceutical (NYSE:PRX):

Needham reiterated its rating of Strong Buy for this company and changed its price target from $42 to $48.

Park-Ohio (NASDAQ:PKOH):

FBR Capital reiterated its rating of Outperform for this company and changed its price target from $25 to $27.

Fossil (NASDAQ:FOSL):

FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $110 to $95.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.